Saturday 17 October 2026
Export AGL’s income statement to Excel — free account
Agilon Health, Inc.
AGL Healthcare Medical Care Facilities
Agilon Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, down 2.11% from fiscal 2024. In the quarter to June 2026, revenue grew 7.15%, EPS grew 117.1%, free cash flow fell 50.2% and total debt fell 13.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.
85.12
3.33
−3.76%
Follow AGL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 3 | 2 | 4 |
| (69.98%) | (130.95%) | (104.02%) | (72.97%) | ||
| (16.72%) | (26.04%) | (20.63%) | (14.06%) | ||
ROIC |
(781.56%) | 0.00% | 0.00% | (34,218.16%) | |
Return on Tangible Assets |
(248.00%) | (857.67%) | (480.83%) | (177.67%) | |
Average Days of Receivables |
58.74 | 41.45 | 56.42 | 65.34 | |
Free Cash Flow per Share |
(6.91) | (8.99) | (5.14) | (6.34) | |
Free Cash Flow |
(114.58) | (148.87) | (85.40) | (105.98) | |
Capital Expenditures |
(45.77) | (43.11) | (35.35) | (33.72) | |
| Other line items | |||||
Cash ROIC |
(17.58%) | (33.31%) | (16.60%) | (20.58%) | |
Accounts Receivable Turnover |
5.08 | 7.02 | 5.44 | 5.62 | |
Accounts Payable Turnover |
32.93 | 35.03 | 27.80 | 26.44 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
8.86 | 7.64 | 12.39 | 16.99 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.01 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
4.05% | 4.02% | 3.90% | 4.38% | |
Share Based Compensation of Revenue |
0.71% | 0.83% | 0.66% | 0.80% | |
Interest Coverage |
(58.09) | (69.75) | (63.01) | (44.36) | |
Operating CF/Net income |
0.22 | 0.27 | 0.14 | 0.31 | |
Depreciation/Fixed assets |
1.08 | 1.13 | 1.15 | 1.14 | |
Capex/Depreciation |
(1.63) | (1.51) | (1.24) | (1.20) | |
Revenue per Share |
355.01 | 358.27 | 350.64 | 354.39 | |
Operating CF per Share |
(4.15) | (6.39) | (3.02) | (4.33) | |
Capex per Share |
(2.76) | (2.60) | (2.13) | (2.02) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates